Compare GROY & IAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GROY | IAM |
|---|---|---|
| Founded | 2020 | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 702.0M | 683.0M |
| IPO Year | 2020 | 2026 |
| Metric | GROY | IAM |
|---|---|---|
| Price | $2.62 | $12.88 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $5.03 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 739.1K |
| Earning Date | 11-04-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $111.19 | N/A |
| Revenue Next Year | $20.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.45 | $13.02 |
| 52 Week High | $5.45 | $24.49 |
| Indicator | GROY | IAM |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 7.28 |
| Support Level | $2.45 | N/A |
| Resistance Level | $2.72 | $16.50 |
| Average True Range (ATR) | 0.11 | 2.34 |
| MACD | -0.01 | -0.63 |
| Stochastic Oscillator | 0.00 | 4.21 |
Gold Royalty Corp is principally engaged in acquiring gold-focused royalties, streaming, and similar interests. It is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. The Company operates in Bosnia and Herzegovina, Canada, which generates maximum revenue, the USA, Brazil, and Mexico.
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.